| Functionally defined therapeutic targets in diffuse intrinsic pontine glioma CS Grasso, Y Tang, N Truffaux, NE Berlow, L Liu, MA Debily, MJ Quist, ... Nature medicine 21 (6), 555-559, 2015 | 669 | 2015 |
| Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, ... Journal of clinical oncology 36 (14), 1419-1427, 2018 | 657 | 2018 |
| A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool L Manterola, E Guruceaga, JG Pérez-Larraya, M González-Huarriz, ... Neuro-oncology 16 (4), 520-527, 2014 | 390 | 2014 |
| MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells N Bitarte, E Bandres, V Boni, R Zarate, J Rodriguez, M Gonzalez-Huarriz, ... Stem cells 29 (11), 1661-1671, 2011 | 326 | 2011 |
| Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death H Jiang, C Gomez-Manzano, H Aoki, MM Alonso, S Kondo, F McCormick, ... Journal of the National Cancer Institute 99 (18), 1410-1414, 2007 | 326 | 2007 |
| Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas MM Alonso, R Diez-Valle, L Manterola, A Rubio, D Liu, N Cortes-Santiago, ... PloS one 6 (11), e26740, 2011 | 282 | 2011 |
| DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients N García-Romero, J Carrión-Navarro, S Esteban-Rubio, E Lazaro-Ibanez, ... Oncotarget 8 (1), 1416, 2016 | 259 | 2016 |
| Sarcoma treatment in the era of molecular medicine TGP Grünewald, M Alonso, S Avnet, A Banito, S Burdach, F Cidre‐Aranaz, ... EMBO molecular medicine 12 (11), e11131, 2020 | 237 | 2020 |
| Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 208 | 2016 |
| Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter MM Alonso, C Gomez-Manzano, BN Bekele, WKA Yung, J Fueyo Cancer research 67 (24), 11499-11504, 2007 | 180 | 2007 |
| PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect I Cristobal, L Garcia-Orti, C Cirauqui, MM Alonso, MJ Calasanz, ... Leukemia 25 (4), 606-614, 2011 | 168 | 2011 |
| Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma J Gállego Pérez-Larraya, M Garcia-Moure, S Labiano, A Patiño-García, ... New England Journal of Medicine 386 (26), 2471-2481, 2022 | 167 | 2022 |
| The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models N Martínez-Vélez, M Garcia-Moure, M Marigil, M González-Huarriz, ... Nature communications 10 (1), 2235, 2019 | 147 | 2019 |
| The RB-E2F1 pathway regulates autophagy H Jiang, V Martin, C Gomez-Manzano, DG Johnson, M Alonso, E White, ... Cancer research 70 (20), 7882-7893, 2010 | 146 | 2010 |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 137 | 2023 |
| Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death MM Alonso, H Jiang, T Yokoyama, J Xu, NB Bekele, FF Lang, S Kondo, ... Molecular Therapy 16 (3), 487-493, 2008 | 136 | 2008 |
| A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients S Inogés, S Tejada, ALD de Cerio, J Gállego Pérez-Larraya, J Espinós, ... Journal of translational medicine 15, 1-12, 2017 | 133 | 2017 |
| Systemic toxicity–efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway M Cascallo, MM Alonso, JJ Rojas, A Perez-Gimenez, J Fueyo, R Alemany Molecular Therapy 15 (9), 1607-1615, 2007 | 125 | 2007 |
| Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 116 | 2018 |
| Role of SOX family of transcription factors in central nervous system tumors AMA de la Rocha, N Sampron, MM Alonso, A Matheu American journal of cancer research 4 (4), 312, 2014 | 107 | 2014 |
ricardo diez valleHospitales Grupo Quiron. FJD, Ruber internacionalVerified email at quironsalud.es